Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Gyre Therapeutics, Inc. (GYRE) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Gyre Therapeutics, Inc. (GYRE), most recent 12 months reported: revenue $119.38M, net loss $18.47M, free cash flow -$6.11M. Latest balance sheet on file: liquid cash $74.8M. From SEC filings. Others in Pharmaceutical Preparations: Karyopharm Therapeutics Inc. · Elite Pharmaceuticals, Inc. · Zevra Therapeutics, Inc. · LIFECORE BIOMEDICAL, INC. · Arcus Biosciences, Inc. · ARS Pharmaceuticals, Inc. · Eton Pharmaceuticals, Inc. · Xencor, Inc

Stock screener

Watchlist